News | September 29, 2009

Cook Wins Stent Graft Patent Infringement Appeal Filed By Edwards

September 29, 2009 – The United States Court of Appeals for the Federal Circuit last week affirmed the previous ruling of the United States District Court for the Northern District of California that Cook Incorporated does not infringe on Edwards’ patents for endovascular devices to treat aneurysms, Cook officials said.

“Since 2003, when this case began, we have remained steadfast that the claims were without merit, and we aggressively defended this case on that basis,” said Cynthia Kretz, general counsel for Cook. The company was represented by the law firm of Brinks Hofer Gilson & Lione in the litigation.

The original case, C 03-03817 JSW, involved Edwards claiming patent infringement on four of Cook’s Zenith endovascular stent-grafts for use in treating abdominal aortic aneurysms (AAAs) and thoracic aortic aneurysms (TAAs).

The United States Court of Appeals for the Federal Circuit reaffirmed the District Court’s ruling “that no reasonable jury could find infringement” or “conclude that Cook’s accused devices” literally infringed the Edwards patents, and “that Edwards cannot, as a matter of law, show that Cook’s accused devices infringe the patents-in-suit under the doctrine of equivalents. Cook, therefore, is entitled to judgment in its favor on this basis as well,” the court wrote in its original decision.

For more information: www.cookmedical.com

Related Content

Endologix Reports Positive One-Year Results From the Ovation LUCY Study
News | Stent Grafts | July 16, 2018
Endologix Inc. announced one-year results from the LUCY (Evaluation of FemaLes who are Underrepresented Candidates for...
FDA Committee Votes in Favor of Incraft AAA Stent Graft System
News | Stent Grafts | June 13, 2018
Cardinal Health announced that its Incraft Abdominal Aortic Aneurysm (AAA) Stent Graft System has received a favorable...
First Patient Enrolled in Gore Excluder Investigational Study
News | Stent Grafts | January 08, 2018
January 8, 2018 — W. L. Gore & Associates Inc.
FDA Concerned About Increase in stent graft Endovascular Type III Leaks
News | Stent Grafts | October 09, 2017
October 9, 2017 — The U.S.
Gore Announces First-in-Human Use of Gore TAG Conformable Thoracic Stent Graft
News | Stent Grafts | July 17, 2017
W. L. Gore & Associates Inc. announced the first patient implant of the Gore TAG Conformable Thoracic Stent Graft...
News | Stent Grafts | April 06, 2017
Endologix Inc. announced that the first patients were treated in the Expanding Patient Applicability with Polymer...
Gore, Viabahn VBX Balloon Expandable Endoprosthesis, stent graft, iliac artery, FDA approval
Technology | Stent Grafts | January 31, 2017
W. L. Gore & Associates (Gore) announced that the Gore Viabahn VBX Balloon Expandable Endoprosthesis (VBX Stent...
Lombard Medical, Aorfix endovascular stent graft, Japanese regulatory approval, IntellFlex LP Delivery System
News | Stent Grafts | January 11, 2017
January 11, 2017 — Lombard Medical Inc.
stent grafts, fluid flow model, clotting risk, Journal of Vascular Surgery

An anterior view is shown of the geometries of each of the graft configurations: (A) fenestrated, (B) antegrade branched, (C) retrograde branched, and (D) manifold stent graft. Image courtesy of Taylor Suess, et al.

News | Stent Grafts | January 05, 2017
January 5, 2017 — Whether patients with mechanical heart valves and stents must take blood thinners depends on how ef
News | Stent Grafts | December 13, 2016
Lombard Medical Inc. announced that its Altura endovascular stent graft system was featured in a scientific...
Overlay Init